Back to search
Local Advanced or Metastatic NSCLC
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Local Advanced or Metastatic NSCLC trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Local Advanced or Metastatic NSCLC trials you may qualify forA study to investigate efficacy and safety of ceralasertib plus durvalumab in participants aged ≥ 18 years with advanced or metastatic non-small cell lung cance…
This is a phase 3, open-label, randomized, multi-center study assessing the efficacy and safety of DZD9008 versus platinum-based doublet chemotherapy in partici…